Even though the overall titer of anti-S antibodies does not necessarily reflect their neutralizing activity, the lack of effect associated with the antibody levels may reinforce the view of an increased chance of CP beneficial effect provided the plasma is administered shortly after the clinical diagnosis of COVID-19. Here, CP is linked to COVID-19.